Case Reports of DRESS Syndrome and Symptoms Consistent with DRESS Syndrome Following Treatment with Recently Marketed Monoclonal Antibodies

BACKGROUND: Monoclonal antibodies constitute a potent and broadly tolerable drug class, representing for some conditions the first newly approved treatment in years. As such, many are afforded “fast-track” or “breakthrough therapy” designations by the U.S. Food and Drug Administration, leading to pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Palma-Grisi, James C., Vijayagopal, Kesav, Muslimani, Muhammad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594346/
https://www.ncbi.nlm.nih.gov/pubmed/31308976
http://dx.doi.org/10.1155/2019/7595706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594346/
https://www.ncbi.nlm.nih.gov/pubmed/31308976
http://dx.doi.org/10.1155/2019/7595706

Ejemplares similares